Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2c2459d9831616925869af1a2de323e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-00 |
filingDate |
2004-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_873d57c8884b86fe2596766f99a90485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e0e30d136a17870936744806809b52f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc96d7c152f80ba9c4ecd991bc6b686c |
publicationDate |
2004-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2004202649-A1 |
titleOfInvention |
Identification of the MECA-79 antigen and related methods of treating L-selectin-mediated conditions |
abstract |
The present invention provides the structure of the MECA-79 antigen and methods of treating L-selectin-mediated conditions by modulating enzymes that are required for formation of this antigen. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005222011-A1 |
priorityDate |
2000-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |